GPC3 and hepatocellular carcinoma: If the diagnosis of HCC cannot be confirmed by typical contrast agent behavior in imaging, the EASL guidelines recommend a biopsy (19), with subsequent staining of HSP70, Glypican-3 (GPC3), and glutamine synthetase (GS).